Voyageur Pharmaceuticals Stock Current Ratio
| VM Stock | CAD 0.05 0.01 9.09% |
Voyageur Pharmaceuticals fundamentals help investors to digest information that contributes to Voyageur Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Voyageur Stock. The fundamental analysis module provides a way to measure Voyageur Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Voyageur Pharmaceuticals stock.
| Last Reported | Projected for Next Year | ||
| Current Ratio | 18.25 | 19.17 |
Voyageur | Current Ratio |
Voyageur Pharmaceuticals Company Current Ratio Analysis
Voyageur Pharmaceuticals' Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Voyageur Pharmaceuticals Current Ratio | 0.16 X |
Most of Voyageur Pharmaceuticals' fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Voyageur Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Voyageur Current Ratio Driver Correlations
Understanding the fundamental principles of building solid financial models for Voyageur Pharmaceuticals is extremely important. It helps to project a fair market value of Voyageur Stock properly, considering its historical fundamentals such as Current Ratio. Since Voyageur Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Voyageur Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Voyageur Pharmaceuticals' interrelated accounts and indicators.
Click cells to compare fundamentals
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
In accordance with the recently published financial statements, Voyageur Pharmaceuticals has a Current Ratio of 0.16 times. This is 95.82% lower than that of the Pharmaceuticals sector and 95.96% lower than that of the Health Care industry. The current ratio for all Canada stocks is 92.59% higher than that of the company.
Voyageur Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Voyageur Pharmaceuticals' direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Voyageur Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Voyageur Pharmaceuticals by comparing valuation metrics of similar companies.Voyageur Pharmaceuticals is currently under evaluation in current ratio category among related companies.
Voyageur Pharmaceuticals Current Valuation Drivers
We derive many important indicators used in calculating different scores of Voyageur Pharmaceuticals from analyzing Voyageur Pharmaceuticals' financial statements. These drivers represent accounts that assess Voyageur Pharmaceuticals' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Voyageur Pharmaceuticals' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 2.8M | 8.5M | 7.5M | 5.2M | 4.7M | 4.1M | |
| Enterprise Value | 3.1M | 7.8M | 7.5M | 5.3M | 4.7M | 4.0M |
Voyageur Fundamentals
| Return On Equity | -0.71 | ||||
| Return On Asset | -0.28 | ||||
| Current Valuation | 6.73 M | ||||
| Shares Outstanding | 138.81 M | ||||
| Shares Owned By Insiders | 10.21 % | ||||
| Number Of Shares Shorted | 9.54 K | ||||
| Price To Book | 6.28 X | ||||
| EBITDA | (1.34 M) | ||||
| Net Income | (1.4 M) | ||||
| Cash And Equivalents | 27.59 K | ||||
| Total Debt | 40 K | ||||
| Debt To Equity | 28.10 % | ||||
| Current Ratio | 0.16 X | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (991.25 K) | ||||
| Short Ratio | 1.26 X | ||||
| Earnings Per Share | (0.01) X | ||||
| Target Price | 0.55 | ||||
| Beta | 0.49 | ||||
| Market Capitalization | 6.94 M | ||||
| Total Asset | 2.16 M | ||||
| Retained Earnings | (9.13 M) | ||||
| Working Capital | (585.25 K) | ||||
| Net Asset | 2.16 M |
About Voyageur Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Voyageur Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Voyageur Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Voyageur Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Voyageur Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for Voyageur Stock analysis
When running Voyageur Pharmaceuticals' price analysis, check to measure Voyageur Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Voyageur Pharmaceuticals is operating at the current time. Most of Voyageur Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Voyageur Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Voyageur Pharmaceuticals' price. Additionally, you may evaluate how the addition of Voyageur Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |